CAS: 855473-51-7 - Montelukast Methyl Ester
Formula:C36H38ClNO3S
InChI:InChI=1S/C36H38ClNO3S/c1-35(2,40)31-10-5-4-8-26(31)14-18-33(42-24-36(19-20-36)23-34(39)41-3)28-9-6-7-25(21-28)11-16-30-17-13-27-12-15-29(37)22-32(27)38-30/h4-13,15-17,21-22,33,40H,14,18-20,23-24H2,1-3H3/b16-11+/t33-/m1/s1
InChI key:InChIKey=MAWSFAVEWJQZKH-ISYDNLPHSA-N
SMILES:O=C(OC)CC1(CSC(C=2C=CC=C(C=CC=3N=C4C=C(Cl)C=CC4=CC3)C2)CCC=5C=CC=CC5C(O)(C)C)CC1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Montelukast Methyl Ester REF: 86-MM0698.16CAS: 855473-51-7 | - - - | 525.00 € | Tue 10 Dec 24 |
 | Montelukast Methyl Ester REF: 4Z-M-3036CAS: 855473-51-7 | - - - | To inquire | Mon 16 Dec 24 |
 | Montelukast methyl ester REF: 3D-FJB47351CAS: 855473-51-7 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | Montelukast Methyl Ester REF: TR-M568080CAS: 855473-51-7 | - - - | - - - | Discontinued product |
Montelukast Methyl Ester
Controlled ProductCAS:855473-51-7
Formula:
C36H38ClNO3S
Color and Shape:
Neat
Molecular weight:
600.21
Ref: 86-MM0698.16
| 100mg | 525.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-M-3036
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Montelukast methyl ester
CAS:855473-51-7
Montelukast is a leukotriene receptor antagonist that is used to treat asthma and chronic obstructive …
Formula:
C36H38ClNO3S
Purity:
Min. 95%
Molecular weight:
600.2 g/mol
Ref: 3D-FJB47351
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Montelukast Methyl Ester
CAS:855473-51-7
Stability Light Sensitive Applications Montelukast Methyl Ester is an impurity of the antiasthmatic drug Montelukast …
Formula:
C36H38ClNO3S
Color and Shape:
Pale Yellow to Pale Beige Low-Melting Solid
Molecular weight:
600.21
Ref: TR-M568080
| 25mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
